The Efficacy and Safety of Lacosamide for Bipolar Depression A 12-Week Open-Label Pilot Trial

被引:1
|
作者
Kishi, Taro [1 ]
Nomura, Ikuo [1 ,2 ]
Sakuma, Kenji [1 ]
Okuya, Makoto [1 ]
Oya, Kazuto [1 ]
Iwata, Nakao [1 ]
机构
[1] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 4701192, Japan
[2] Moriyama Gen Mental Hosp, Dept Psychiat, Nagoya, Aichi 4638570, Japan
关键词
RATING-SCALE;
D O I
10.1097/JCP.0000000000001347
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:204 / 206
页数:3
相关论文
共 50 条
  • [1] Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study
    Chen, Jun
    Muzina, David J.
    Kemp, David E.
    Conroy, Carla
    Chan, Philip
    Serrano, Mary Beth
    Ganocy, Stephen J.
    Fang, Yiru
    Calabrese, Joseph R.
    Gao, Keming
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (08) : 588 - 595
  • [2] Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week Open-Label Trial
    Pachas, Gladys N.
    Cather, Corinne
    Pratt, Sarah I.
    Hoeppner, Bettina
    Nino, Johanna
    Carlini, Sara V.
    Achtyes, Eric D.
    Lando, Harry
    Mueser, Kim T.
    Rigotti, Nancy A.
    Goff, Donald C.
    Evins, A. Eden
    [J]. JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (02) : 117 - 125
  • [3] Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial
    Tapson, VF
    Gomberg-Maitland, M
    McLaughlin, VV
    Benza, RL
    Widlitz, AC
    Krichman, A
    Barst, RJ
    [J]. CHEST, 2006, 129 (03) : 683 - 688
  • [4] Aripiprazole therapy in 20 older adults with bipolar disorder: A 12-week, open-label trial
    Sajatovic, Martha
    Coconcea, Nicoleta
    Ignacio, Rosalinda V.
    Blow, Frederic C.
    Hays, Robert W.
    Cassidy, Kristin A.
    Meyer, William J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (01) : 41 - 46
  • [5] Effects of bupropion on depression of Parkinson's disease: Open-label 12-week trial in Korea
    Kim, W. C.
    Kim, H. S.
    Oh, S. H.
    Kim, O. J.
    Lee, M. S.
    [J]. MOVEMENT DISORDERS, 2009, 24 : S241 - S241
  • [6] Safety and efficacy of donepezil in a 12-week, open-label trial in African Americans with mild to moderate Alzheimer's disease
    Griffith, P
    Lichtenberg, P
    Goldman, R
    Payne-Parrish, J
    Richardson, S
    [J]. NEUROLOGY, 2005, 64 (06) : A366 - A366
  • [7] Safety and efficacy of donepezil in African Americans with mild to moderate Alzheimer's disease: A 12-week open-label trial.
    Griffith, P
    Lichtenberg, P
    Goldman, R
    Payne-Parrish, J
    Richardson, S
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : S76 - S76
  • [8] A 12-week open-label, randomized, controlled trial and 24-week extension to assess the efficacy and safety of fluticasone propionate/formoterol in children with asthma
    Emeryk, Andrzej
    Klink, Rabih
    McIver, Tammy
    Dalvi, Prashant
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2016, 10 (04) : 324 - 337
  • [9] Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study
    Iyo, Masaomi
    Ishigooka, Jun
    Nakamura, Masatoshi
    Sakaguchi, Reiko
    Okamoto, Keisuke
    Mao, Yongcai
    Tsai, Joyce
    Fitzgerald, Alison
    Takai, Kentaro
    Higuchi, Teruhiko
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 2683 - 2695
  • [10] A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients
    Graham, JA
    Ketter, TA
    Roberts, J
    DeVeaugh-Geiss, AM
    Thompson, TR
    [J]. BIPOLAR DISORDERS, 2005, 7 : 62 - 62